{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:13:32Z","timestamp":1788304412547,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer US","isbn-type":[{"value":"9781071652565","type":"print"},{"value":"9781071652572","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5257-2_6","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:17:10Z","timestamp":1788301030000},"page":"87-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR-Engineered Bacteriophage T4 for Foot-and-Mouth Disease Nanoparticle Vaccine Development"],"prefix":"10.1007","author":[{"given":"Mengling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,2]]},"reference":[{"issue":"1","key":"6_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/v14010022","volume":"14","author":"SM Choudhury","year":"2021","unstructured":"Choudhury SM, Ma X, Li Y, Nian X, Luo Z, Ma Y, Zhu Z, Yang F, Cao W, Zheng H (2021) FMDV leader protein interacts with the NACHT and LRR domains of NLRP3 to promote IL-1\u03b2 production. Viruses 14(1):22. https:\/\/doi.org\/10.3390\/v14010022","journal-title":"Viruses"},{"issue":"8","key":"6_CR2","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/v14081781","volume":"14","author":"S Di Giacomo","year":"2022","unstructured":"Di Giacomo S, Bucafusco D, Schammas JM, Pega J, Miraglia MC, Barrionuevo F, Capozzo AV, Perez-Filgueira DM (2022) Assessment on different vaccine formulation parameters in the protection against heterologous challenge with FMDV in cattle. Viruses 14(8):1781. https:\/\/doi.org\/10.3390\/v14081781","journal-title":"Viruses"},{"issue":"9","key":"6_CR3","doi-asserted-by":"publisher","first-page":"e02157","DOI":"10.1128\/JVI.02157-16","volume":"91","author":"CFJ Grant","year":"2017","unstructured":"Grant CFJ, Carr BV, Kotecha A, van den Born E, Stuart DI, Hammond JA, Charleston B (2017) The B cell response to foot-and-mouth disease virus in cattle following sequential vaccination with multiple serotypes. J Virol 91(9):e02157. https:\/\/doi.org\/10.1128\/JVI.02157-16","journal-title":"J Virol"},{"issue":"3","key":"6_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/v14030621","volume":"14","author":"Y Harvey","year":"2022","unstructured":"Harvey Y, Jackson B, Carr BV, Childs K, Moffat K, Freimanis G, Tennakoon C, Juleff N, Seago J (2022) An improved \u03b1v\u03b26-receptor-expressing suspension cell line for foot-and-mouth disease vaccine production. Viruses 14(3):621. https:\/\/doi.org\/10.3390\/v14030621","journal-title":"Viruses"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"554305","DOI":"10.3389\/fvets.2020.554305","volume":"7","author":"JM Hardham","year":"2020","unstructured":"Hardham JM, Krug P, Pacheco JM, Thompson J, Dominowski P, Moulin V, Gay CG, Rodriguez LL, Rieder E (2020) Novel foot-and-mouth disease vaccine platform: formulations for safe and DIVA-compatible FMD vaccines with improved potency. Front Vet Sci 7:554305","journal-title":"Front Vet Sci"},{"issue":"11","key":"6_CR6","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/vaccines10111817","volume":"10","author":"Z Lu","year":"2022","unstructured":"Lu Z, Yu S, Wang W, Chen W, Wang X, Wu K, Li X, Fan S, Ding H, Yi L et al (2022) Development of foot-and-mouth disease vaccines in recent years. Vaccines 10(11):1817. https:\/\/doi.org\/10.3390\/vaccines10111817","journal-title":"Vaccines"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"3497401","DOI":"10.1155\/2018\/3497401","volume":"2018","author":"I Soria","year":"2018","unstructured":"Soria I, Quattrocchi V, Langellotti C, P\u00e9rez-Filgueira M, Pega J, Gnazzo V, Romera S, Schammas J, Bucafusco D, Di Giacomo S et al (2018) Immune response and partial protection against heterologous foot-and-mouth disease virus induced by dendrimer peptides in cattle. J Immunol Res 2018:3497401","journal-title":"J Immunol Res"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.vaccine.2019.05.019","volume":"37","author":"I Fernandez-Sainz","year":"2019","unstructured":"Fernandez-Sainz I, Gavitt TD, Koster M, Ramirez-Medina E, Rodriguez YY, Wu P, Silbart LK, de Los Santos T, Szczepanek SM (2019) The VP1 G-H loop hypervariable epitope contributes to protective immunity against foot and mouth disease virus in swine. Vaccine 37:3435\u20133442","journal-title":"Vaccine"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/298030a0","volume":"298","author":"JL Bittle","year":"1982","unstructured":"Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30\u201333","journal-title":"Nature"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"e4823","DOI":"10.7717\/peerj.4823","volume":"6","author":"G Wang","year":"2018","unstructured":"Wang G, Liu Y, Feng H, Chen Y, Yang S, Wei Q, Wang J, Liu D, Zhang G (2018) Immunogenicity evaluation of MS2 phage-mediated chimeric nanoparticle displaying an immunodominant B cell epitope of foot-and-mouth disease virus. PeerJ 6:e4823","journal-title":"PeerJ"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1073\/pnas.0406740101","volume":"101","author":"DC Jackson","year":"2004","unstructured":"Jackson DC, Lau YF, Le T, Suhrbier A, Deliyannis G, Cheers C, Smith C, Zeng W, Brown LE (2004) A totally synthetic vaccine of generic structure that targets toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci U S A 101:15440\u201315445","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","volume":"120","author":"RJ Malonis","year":"2020","unstructured":"Malonis RJ, Lai JR, Vergnolle O (2020) Peptide-based vaccines: current progress and future challenges. Chem Rev 120:3210\u20133229","journal-title":"Chem Rev"},{"issue":"3","key":"6_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/v15030797","volume":"15","author":"Q Li","year":"2023","unstructured":"Li Q, Wubshet AK, Wang Y, Heath L, Zhang J (2023) B and T cell epitopes of the incursionary foot-and-mouth disease virus serotype SAT2 for vaccine development. Viruses 15(3):797. https:\/\/doi.org\/10.3390\/v15030797","journal-title":"Viruses"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/jmv.25554","volume":"91","author":"Y Lei","year":"2019","unstructured":"Lei Y, Shao J, Zhao F, Li Y, Lei C, Ma F, Chang H, Zhang Y (2019) Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate. J Med Virol 91:2142\u20132152","journal-title":"J Med Virol"},{"issue":"2","key":"6_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/vaccines8020254","volume":"8","author":"MJ Lee","year":"2020","unstructured":"Lee MJ, Jo H, Park SH, Ko MK, Kim SM, Kim B, Park JH (2020) Advanced foot-and-mouth disease vaccine platform for stimulation of simultaneous cellular and humoral immune responses. Vaccines 8(2):254. https:\/\/doi.org\/10.3390\/vaccines8020254","journal-title":"Vaccines"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"745625","DOI":"10.3389\/fimmu.2021.745625","volume":"12","author":"M Li","year":"2021","unstructured":"Li M, Guo P, Chen C, Feng H, Zhang W, Gu C, Wen G, Rao VB, Tao P (2021) Bacteriophage T4 vaccine platform for next-generation influenza vaccine development. Front Immunol 12:745625","journal-title":"Front Immunol"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"e1003495","DOI":"10.1371\/journal.ppat.1003495","volume":"9","author":"P Tao","year":"2013","unstructured":"Tao P, Mahalingam M, Kirtley ML, van Lier CJ, Sha J, Yeager LA, Chopra AK, Rao VB (2013) Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines. PLoS Pathog 9:e1003495","journal-title":"PLoS Pathog"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"105688","DOI":"10.1016\/j.antiviral.2023.105688","volume":"217","author":"M Li","year":"2023","unstructured":"Li M, Chen C, Wang X, Guo P, Feng H, Zhang X, Zhang W, Gu C, Zhu J, Wen G et al (2023) T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines. Antiviral Res 217:105688","journal-title":"Antiviral Res"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1021\/acssynbio.1c00251","volume":"10","author":"J Dong","year":"2021","unstructured":"Dong J, Chen C, Liu Y, Zhu J, Li M, Rao VB, Tao P (2021) Engineering T4 Bacteriophage for in vivo display by type V CRISPR-cas genome editing. ACS Synth Biol 10:2639\u20132648","journal-title":"ACS Synth Biol"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"128837","DOI":"10.1016\/j.ijbiomac.2023.128837","volume":"258","author":"C Chen","year":"2023","unstructured":"Chen C, Zhang N, Li M, Guo A, Zheng Y, Humak F, Qian P, Tao P (2023) Recombinant bacteriophage T4 displaying key epitopes of the foot-and-mouth disease virus as a novel nanoparticle vaccine. Int J Biol Macromol 258:128837","journal-title":"Int J Biol Macromol"}],"container-title":["Methods in Molecular Biology","Biological Macromolecule Engineering Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5257-2_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:17:11Z","timestamp":1788301031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5257-2_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071652565","9781071652572"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5257-2_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 August 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}